RECRUITING

A Patient-Centric Platform Trial for Precision Oncology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Official Title

xCures/CancerCommons Enhanced Learning Treatment Selection and Analysis With Outcomes Research (XCELSIOR) Study: A Patient-Centric Platform Trial for Precision Oncology

Quick Facts

Study Start:2019-02-07
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03793088

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
  2. * Patients with any performance status, comorbidity or disease severity are eligible
  3. * Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)
  1. * Patients must be a resident of or receiving care within the United States or US territories.

Contacts and Locations

Study Contact

Bryan J Federowicz
CONTACT
707-641-4475
bfederowicz@xcures.com

Principal Investigator

Mark Shapiro
PRINCIPAL_INVESTIGATOR
xCures / Cancer Commons

Study Locations (Sites)

Cancer Commons
Los Altos, California, 94022
United States

Collaborators and Investigators

Sponsor: xCures

  • Mark Shapiro, PRINCIPAL_INVESTIGATOR, xCures / Cancer Commons

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-02-07
Study Completion Date2026-01

Study Record Updates

Study Start Date2019-02-07
Study Completion Date2026-01

Terms related to this study

Keywords Provided by Researchers

  • Glioblastoma
  • Glioma
  • Pancreatic Adenocarcinoma

Additional Relevant MeSH Terms

  • Oncology